Tip Sheets for Care Managers
Below are the Collaborative Care Tip Sheets for Alternative Treatments for Depression
Alternative Treatments for Depression Tip Sheet
Download Tip Sheet
Alternative Treatments for Depression Slide Deck
Download Slide Deck (coming soon)
Understanding Perinatal Depression
Challenges with Antidepressants:
- Antidepressants often require weeks to months to take full effect.
- Prolonged risk to mother and infant can occur during the delay in therapeutic effect.
- SSRI efficacy in postpartum depression (PPD) is well-documented but not superior to other treatments.
Alternative Treatments for Perinatal Depression
Transcranial Magnetic Stimulation (TMS):
- Non-invasive brain stimulation, effective for treatment-resistant depression.
- Suitable for patients avoiding antidepressants
- Has been tested in pregnant women (small studies) but is not currently standard of care
- Typical protocol: 15–20 minutes/day, 5 days/week for 6 weeks.
- Side effects: Headaches are common; seizures and other adverse effects are rare.
Electroconvulsive Therapy (ECT):
- Indicated for severe cases involving suicidality, psychosis, or catatonia.
- Safe and effective during pregnancy, with most complications being mild or moderate.
- Used when psychotherapy and medication are ineffective or contraindicated.
Light Therapy:
- In small studies, was shown to be effective for non-seasonal major depressive disorder in pregnancy.
- Protocol: 7000 lux bright light therapy for 1 hour/day in the morning over 5 weeks.
- No reported side effects or perinatal complications.
Allopregnanolone-Based Treatment:
Zuranolone:
- An oral version of allopregnanolone that was approved by the FDA in August 2023 for treatment of PPD.
- Significant improvement seen within 3 days; sustained effects at 45 days.
- Common side effects include dizziness and sedation.
Key Considerations and Barriers
Barriers to Care:
- Limited access to specialized perinatal psychiatric services.
- Financial burdens and lack of family support.
- Cultural biases and stigma may prevent patients from seeking treatment.
Safety and Monitoring:
- TMS: Safe with minimal side effects, appears to be suitable for pregnancy.
- ECT: Requires careful monitoring for complications but remains effective.
Collaborative Care Tips
Patient-Centered Support:
- Educate patients on the range of treatment options, including newer therapies.
- Address stigma and cultural barriers to mental health treatment.
- Monitor patient progress and maintain safety, especially during interventions